Interventions to improve outcomes in community-acquired pneumonia

被引:3
作者
Cilloniz, Catia [1 ,2 ,5 ]
Pericas, Juan Manuel [3 ]
Curioso, Walter H. [2 ,4 ]
机构
[1] IDIBAPS, Ctr Biomed Res Resp Dis Network CIBERES, Barcelona, Spain
[2] Univ Continental, Fac Ciencias Salud, Huancayo, Peru
[3] Vall Hebron Univ Hosp, Vall Hebron Inst Res VHIR, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Internal Med Dept,Liver Unit, Barcelona, Spain
[4] Continental Univ Florida, Hlth Serv Adm, Margate, FL USA
[5] Univ Barcelona, IDIBAPS Hosp Clin Barcelona, C Villarroel 170, Barcelona 08036, Spain
关键词
Pneumonia; community-acquired pneumonia; outcomes; severe pneumonia; respiratory infection; ACUTE MYOCARDIAL-INFARCTION; MULTIDRUG-RESISTANT PATHOGENS; INFECTIOUS-DISEASES-SOCIETY; AMERICAN THORACIC SOCIETY; BETA-LACTAM MONOTHERAPY; CRITICALLY-ILL PATIENTS; HIGH-FLOW OXYGEN; HOSPITALIZED-PATIENTS; RISK-FACTORS; CLINICAL STABILITY;
D O I
10.1080/14787210.2023.2257392
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
IntroductionCommunity-acquired pneumonia (CAP) is a common infection associated with high morbimortality and a highly deleterious impact on patients' quality of life and functionality. We comprehensively review the factors related to the host, the causative microorganism, the therapeutic approach and the organization of health systems (e.g. setting for care and systems for allocation) that might have an impact on CAP-associated outcomes. Our main aims are to discuss the most controversial points and to provide some recommendations that may guide further research and the management of patients with CAP, in order to improve their outcomes, beyond mortality.Area coveredIn this review, we aim to provide a critical account of potential measures to improve outcomes of CAP and the supporting evidence from observational studies and clinical trials.Expert opinionCAP is associated with high mortality and a highly deleterious impact on patients' quality of life. To improve CAP-associated outcomes, it is important to understand the factors related to the patient, etiology, therapeutics, and the organization of health systems.
引用
收藏
页码:1071 / 1086
页数:16
相关论文
共 50 条
  • [41] Community-acquired pneumonia
    Aliberti, Stefano
    Dela Cruz, Charles S.
    Amati, Francesco
    Sotgiu, Giovanni
    Restrepo, Marcos I.
    [J]. LANCET, 2021, 398 (10303) : 906 - 919
  • [42] Community-acquired pneumonia
    Welte, T.
    [J]. INTERNIST, 2009, 50 (03): : 331 - 339
  • [43] Community-acquired pneumonia
    Falguera, M.
    Ramirez, M. F.
    [J]. REVISTA CLINICA ESPANOLA, 2015, 215 (08): : 458 - 467
  • [44] Outcomes of Macrolide Deescalation in Severe Community-acquired Pneumonia
    Hopkins, Tiffany M.
    Juang, Paul
    Weaver, Katherine
    Kollef, Marin H.
    Betthauser, Kevin D.
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (12) : 2540 - 2548
  • [45] Community-acquired pneumonia and procalcitonin, an opportunity to improve?
    Tudela, Pere
    Maria Modol, Josep
    [J]. MEDICINA CLINICA, 2014, 142 (07): : 303 - 305
  • [46] Risk of Multidrug-Resistant Pathogens in Severe Community-Acquired Pneumonia
    Campana-Duel, E.
    Camprubi-Rimblas, M.
    Areny-Balaguero, A.
    Quero, Sara
    Artigas, A.
    Ceccato, A.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (02) : 246 - 254
  • [47] Effect of Undernutrition and Obesity on Clinical Outcomes in Adults with Community-Acquired Pneumonia
    Viasus, Diego
    Perez-Vergara, Valentina
    Carratala, Jordi
    [J]. NUTRIENTS, 2022, 14 (15)
  • [48] Community-Acquired Pneumonia: An Unfinished Battle
    Nair, Girish B.
    Niederman, Michael S.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (06) : 1143 - +
  • [49] Predictors and impact of time to clinical stability in community-acquired pneumococcal pneumonia
    Takada, Kazuto
    Matsumoto, Shuuichi
    Kojinia, Eiji
    Iwata, Susumu
    Ninomiya, Kiyoko
    Tanaka, Kentarou
    Goto, Daiki
    Shimizu, Takahiro
    Nohara, Kango
    [J]. RESPIRATORY MEDICINE, 2014, 108 (05) : 806 - 812
  • [50] Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes
    Cilloniz, C.
    Ewig, S.
    Polverino, E.
    Munoz-Almagro, C.
    Marco, F.
    Gabarrus, A.
    Menendez, R.
    Mensa, J.
    Torres, A.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (11) : 1134 - 1142